Compară metode

	Testul de Impact al Durerii de Cap HIT-6	EORTC QLQ-C30
Domeniu	Rezultate în sănătate	Rezultate în sănătate
Familie	Process / pipeline	Process / pipeline
Anul apariției	2003	1993
Autorul original	Mark Kosinski et al.	Nico Aaronson et al.
Tip	Self-report functional impact questionnaire	Self-report quality of life questionnaire
Sursa seminală	Kosinski, M., Bayliss, M. S., Bjorner, J. B., Ware, J. E., Garber, W. H., Batenhorst, A., & Tepper, S. (2003). A six-item short-form survey for measuring headache impact: The HIT-6. Quality of Life Research, 12(8), 963-974.	Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., ... & Takeda, F. (1993). The European Organisation for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute, 85(5), 365-376.
Denumiri alternative	HIT-6, Headache Impact Test, HIT	QLQ-C30, EORTC QLQ-C30, Cancer Quality of Life Scale
Înrudite	4	5
Rezumat	The HIT-6 is a brief, validated measure of headache impact on daily functioning and quality of life. Developed by Mark Kosinski and colleagues in 2003, this 6-item questionnaire quantifies how headache (migraine or other types) affects work, social activities, sleep, and emotional well-being. It is widely used in headache research, clinical trials, and practice to assess disease burden and treatment benefit.	The EORTC QLQ-C30 is the most widely used international instrument for assessing quality of life in cancer patients. Developed by the European Organisation for Research and Treatment of Cancer in 1993, it measures physical, emotional, cognitive, and social functioning alongside cancer-specific symptoms and financial impact, making it the standard outcome measure in oncology clinical trials and patient care.